|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |
Abstract |
|---|
|
|
|---|
In mammals, including rats and mice, the development of pulmonary alveolar septa is primarily limited to late gestation
and the early periods of postnatal life. Before this time, the rat lung contains a relatively large supply of endogenous retinyl ester that, together with its metabolite retinoic acid, has been shown to increase elastin gene expression and the number of
alveoli. We have hypothesized that mice bearing a deletion of
one or more genes encoding for retinoic acid receptors (which
are DNA binding proteins that alter transcription of retinoic
acid-responsive genes) may demonstrate abnormalities in retinoid-mediated alveolar formation. Our studies demonstrate
that the absence of the retinoic acid receptor-gamma (RAR
)
is associated with a decrease in the steady-state level of tropoelastin messenger RNA in a subpopulation of lung fibroblasts at Postnatal Day 12. RAR
gene deletion also resulted in
a decrease in whole lung elastic tissue and alveolar number,
and an increase in mean cord length of alveoli (Lm) at Postnatal Day 28. The additional deletion of one retinoid X receptor (RXR)
allele resulted in a decrease in alveolar surface area and alveolar number, and an increase in L m. These data indicate that RAR
is required for the formation of normal alveoli
and alveolar elastic fibers in the mouse, and that RAR/RXR
heterodimers are involved in alveolar morphogenesis.
| |
Introduction |
|---|
|
|
|---|
There is growing evidence that retinoids, and in particular all-trans retinoic acid (tRA), are involved in the development of both the conducting airway and alveolar portions of the lungs (1). Retinoids are a family of molecules whose biologically active members are collectively called "vitamin A." Most cells acquire retinol from plasma, although a few organs like the liver, kidney, and lungs contain retinyl ester hydrolases and can presumably acquire retinol from the hydrolysis of endogenous retinyl esters (2). Before interacting with retinoid responsive genes, retinol is usually converted to tRA. Massaro and Massaro (3, 4) have shown that tRA increases the number of alveoli in neonatal rats and restores alveolar number and alveolar surface area in an animal model of emphysema. These data suggest that tRA enhances alveolar formation, but the mechanisms responsible for this enhancement have not been elucidated.
Alveolar formation involves a coordinated increase in
epithelial and mesenchymal cells, the protrusion of primary and secondary alveolar septa into the air spaces, and
the formation of an extracellular connective tissue framework for the newly formed septa (5). Elastic fibers are a
critical element of this supporting framework and are essential to the alveolar septation process (6). More recently,
Boström and associates (7) have shown that the platelet-derived growth factor-A null deletion in mice results in a
marked reduction in the number of
-smooth muscle actin
containing alveolar septal cells that produce elastin at Postnatal Day 10 and older. The marked diminution of elastin-producing interstital cells was accompanied by a failure of
the formation of secondary septa. This resulted in markedly dilated distal air sacs at Postnatal Day 19. Elastin is a
hydrophobic protein that confers elastic properties to the lung and reduces the mechanical energy required for respiration (8). Elastin is synthesized as a soluble monomer,
tropoelastin (TE), and is secreted into the extracellular space
where it is covalently cross-linked to other TE molecules, in
the presence of various fibrillar glycoproteins, to form insoluble elastic fibers (8).
Endogenous retinoids increase lung elastin gene expression during Gestational Days 19 through 22 in the rat lung when retinyl esters are most abundant and may be required for concurrent saccular development (9). We have previously shown that exogenous tRA increases elastin gene expression by a subpopulation of lipid-laden, myofibroblast-like lung fibroblasts in vitro (12, 13). These fibroblasts are elastin-producing lung fibroblasts that accumulate lipid and are abundant during the first two postnatal weeks in mice (14). Because the development of the elastic fiber network in the pulmonary interstitium occurs hand-in-hand with alveolar morphogenesis, we hypothesized that the stimulation of pulmonary alveolar formation by tRA is accompanied by an increase in elastin gene expression. To test this hypothesis, we examined elastin gene expression, elastic fiber formation, and alveolar number and surface area in mice whose endogenous retinoid signaling pathway had been disrupted by deletions of specific retinoic acid receptor (RAR) genes.
Retinoids alter gene expression by binding to RARs,
which bind tRA or its isomer 9-cis-RA, and to retinoid X
receptors (RXR), which bind only 9-cis-RA (15). RARs
and RXRs heterodimerize in solution, thereby forming a
complex that binds with high affinity to DNA response elements, termed retinoic acid response elements (RARE),
upstream from the promoters of target genes. RAR
is expressed in the murine lung during embryogenesis primarily in late gestation (after 15 d of gestation in the mouse)
and appears in the mesenchymal cells of the distal lung (16).
Specific RAR and RXR gene deletions have been created
in mice using homologous recombination (17). In general,
deletion of one family member, such as RAR
or RAR
,
does not result in an abnormal phenotype in the lung (18).
In contrast, the deletion of RAR
is associated with defects in tracheal cartilages, and as a group, the animals
have a shortened life span (19). RXR
and RXR
gene
deletions have also been described (20, 21). RXR
is expressed in the lungs of adult rats and mice (22). RXR
/
mice demonstrate a delayed embryonic maturation of
their lungs and liver, but the most pronounced abnormality is a hypoplastic thin cardiac ventricular wall, which precludes development beyond Gestational Day 17 (20). Mice
with compound deletions of RAR
and RXR
have been
reported but their lungs have not been studied in detail (23).
| |
Materials and Methods |
|---|
|
|
|---|
Mouse RAR
and RXR
Gene Targeting and Breeding
Female RAR
+/
and male RXR
+/
mice were provided by
Dr. Pierre Chambon and bred at the Animal Research Facility at
the Iowa City Veterans Affairs Medical Center, following an approved protocol. The targeted disruption of these genes has been
described previously (19, 20). The mice were fed Harlan Teklab-7001 mouse and rat chow and watered ad libitum. Male and female
mice that were RAR
+/
,RXR
+/
(heterozygotic for both the
RAR
and RXR
null mutations) were obtained and bred. Tail biopsies were performed at Postnatal Day 5 and genomic DNA was
isolated. DNA bearing RAR
and RXR
deletions was identified
using the polymerase chain reaction (PCR) and Southern blot analysis. Genomic DNA was also subjected to Southern blot analysis to
confirm the genotypes that were determined using PCR (20). Probe 1 was used to detect the RAR
gene and is a complementary DNA
(cDNA) that is derived from intron 7, immediately 5' to exon 8 (19).
Probe B was used to detect the RXR
gene and is a cDNA that is derived from intron 2, exon 3, and a portion of intron 3 (20). Based on
the results from analysis by PCR, homozygotes for the RAR
deletion were killed between Postnatal Days 10 and 12, and the lung was
removed. The body and lung weights were recorded and a portion of
the lung was immediately frozen in liquid nitrogen and stored at
75°C. The remainder of the lung was used for the isolation of lipid-laden interstitial fibroblasts (LIFs). The isolation procedure was similar to that for rats except that the discontinuous Percoll gradients were formed in 15-ml rather than 50-ml tubes and contained 2.5 ml
per layer (13). Greater than 80% of the cells that sedimented at a
density of 1.04 contained neutral lipid droplets and vimentin intermediate filaments, characteristic of lipid-laden mesenchymal cells (13).
Administration of tRA to Neonatal Rats
Because others have shown that postnatal administration of tRA increases alveolar number, we determined whether this treatment resulted in an increase in TE messenger RNA (mRNA) (3). Rats were chosen because the effects of tRA on the early postnatal alveolar development have been more completely described in rats than in mice (24). Two groups of four rats were given daily intraperitoneal injections from Postnatal Days 2 through 11 of either 0.5 mg/kg of tRA (1 mg/ml) in safflower oil or safflower oil alone. On Postnatal Day 12, the rats were killed and lung tissue was removed. Some of the lung tissue was used directly for RNA isolation while the remainder was used to isolate LIFs, using the procedure that has been described (25). Northern blot analysis was performed to compare the steady-state levels of TE mRNA in control and tRA-treated animals (25). Three experiments were performed using different litters of rats.
Analysis of TE mRNA
Total RNA was isolated from either whole lung tissue or isolated LIFs obtained from mice or rats, using guanidine isocyanate, subjected to denaturing electrophoresis on 1.5% agarose, and transferred to cationic nylon membranes (25). The membranes were successively probed with the partial cDNAs for rat TE and ribosomal phosphoprotein P-0 (RP-0) (10). RP-0 is constitutively expressed and served as a control for loading differences. Autoradiograms were prepared and the exposure times were limited so the densities were within the linear range of the film. Autoradiograms were scanned using a densitometer, and the densities of the bands containing TE mRNA were expressed relative to the densities of the corresponding bands containing RP-0.
Quantification of Elastin
The lungs from control and transgenic mice at Postnatal Day 28 were perfused with phosphate-buffered saline and removed; the lobes were separated, blotted dry, and weighed, and frozen in liquid nitrogen. A portion of the tissue was used to isolate elastin by extracting with hot alkali (12). The washed, alkali-resistant, insoluble elastin residue was hydrolyzed for 20 h in 6 N HCl under vacuum, and the HCl was removed by evaporation under a stream of nitrogen. The amino-acid composition of the hydrolysate was analyzed using reverse-phase high performance liquid chromatography following a procedure that has been described previously (12).
Histologic Preparation and Analysis
Mice were weighed and killed at Postnatal Day 28, and the anterior chest wall was removed. The lungs were perfused with 2% paraformaldehyde via the right ventricle, buffered in 0.1 M Na-phosphate, pH 7.0. The trachea was cannulated and the cannula was tied firmly in place. The trachea and lungs were infused with 2% paraformaldehyde at 20 cm H2O pressure and maintained at this pressure for 18 h at 4°C. The lungs were monitored carefully for the initial 10 min, and only lungs that did not leak during this time were used for fixation and embedding. After fixation, the lungs were removed from the chest cavity, the lobes were separated, and the heart and mediastinal tissues were removed. The lungs were dehydrated through a graded series of ethanol. Finally, the lobes were placed into individual cassettes and embedded in paraffin. The central portions of the blocks were sectioned at 3.5-micron intervals, and the sections were mounted on glass slides, deparaffinized, hydrated, and stained with hematoxylin and eosin. Elastic fibers were also identified histologically. Lung tissue sections were obtained from mice with each genotype and were stained concurrently using a modified Van Gieson stain (Sigma Chemical Co., St. Louis, MO), so the intensity of elastic tissue staining could be compared among the various genotypes (26).
Morphometry
Sections were chosen at random, and randomly selected microscopic fields from peripheral (subpleural) and central regions of
the lungs were photographed. The photographs were enlarged uniformly, overlaid with transparent grids, and used for morphometric analysis (27). The volume densities of air and tissue were
determined using point counting; mean cord lengths (Lm) were
determined by counting intersections with an array of lines; and
the numbers of alveoli in rectangles of defined areas were recorded. All morphometric measurements were made by two independent observers who were unaware of the genotypes of the
animals being analyzed. Three to five animals were analyzed per
condition and six photographs were analyzed per animal. The
mean linear intercept and alveolar surface areas were calculated
as described previously and the values determined for control,
RAR
/
,RXR
+/+, and RAR
/
,RXR
+/
animals. Alveolar number was normalized per unit volume (mm3) of the
inflated, paraffin-embedded lung. Means and standard deviations
were calculated and statistical comparisons were performed using
unpaired Student's t test.
Statistical Analyses
The data are expressed as means ± standard error of the mean
(SEM). Comparisons of TE mRNA and elastin in wild-type and
animals bearing gene deletions and in the neonatal rats that received tRA or safflower oil vehicle were made using a two-way
analysis of variance. Morphometric parameters from wild-type and
the respective RAR
/
,RXR
+/+ or RAR
/
, RXR
+/
groups were made using Student's t test for unpaired variables.
Differences were considered significant when P < 0.05 (28).
| |
Results |
|---|
|
|
|---|
TE mRNA Is Decreased in Pulmonary LIF at Postnatal Day 12
Lung tissue was removed, and LIFs were isolated from control mice and mice bearing the RAR
gene deletion at Postnatal Day 12 when the level of TE mRNA is near its maximum (25). The mean body weight and whole lung wet weights
of wild-type mice at Postnatal Day 12 were 4.98 ± 0.54 and
0.105 ± 0.006 g (mean ± SEM, n = 5), respectively. The
corresponding weights for RAR
/
,RXR
+/+ mice
were 5.00 ± 0.73 and 0.103 ± 0.01 g (n = 4), respectively, and for RAR
/
,RXR
+/
mice, 3.36 ± 0.34 and
0.082 ± 0.01 g (n = 4, P < 0.05 compared with wild-type
mice). The number of LIFs that were isolated from wild-type mice (7.60 ± 0.85 × 106, n = 13) was higher when
compared with the RAR
/
,RXR
+/
mice, 3.07 ± 0.39 × 106 (mean ± SEM, n = 3, P < 0.03), whereas wild-type mice were similar to RAR
/
,RXR
+/+ mice
(7.83 ± 1.66 × 106, n = 5). A representative composite autoradiogram demonstrating the abundance of TE (3.5 kb)
and RP-0 (1.1 kb) mRNA in wild-type mice and mice bearing a RAR
gene deletion is shown in Figure 1A. LIFs
isolated from mice that bore the RAR
/
deletion demonstrated an approximately 2-fold decrease in their TE
mRNA that was statistically significant (P < 0.01) when the
mice were also RXR
+/
(Figure 1B). However, the
steady-state levels of TE mRNA in whole lung tissues from
RAR
/
,RXR
+/
or RAR
/
, RXR
+/+ mice
were similar to levels in wild-type mice (Figure 1C).
|
Effects of tRA on Neonatal Rat Lung Elastin Gene Expression
Administering tRA to neonatal rats from Postnatal Days 2 through 11 increases alveolar number (3). Therefore, studies were performed to determine whether tRA administration also produced an increase in TE mRNA (24). The results of these studies are summarized in Figure 2 and indicate that TE mRNA is increased in LIFs but not in whole lung tissue obtained from tRA-treated animals when compared with levels in vehicle-treated control animals.
|
Lung Elastin Content Is Reduced in
RAR
/
,RXR
+/
Mice
Lungs were removed from wild-type mice and mice bearing RAR and RXR gene deletions at 28 d of age, and elastin was isolated and subjected to amino-acid analysis. Elastin content was significantly decreased in the RAR
/
,
RXR
+/
mice (P < 0.05) and was also decreased, but
not significantly, in RAR
/
mice when compared with
levels in wild-type mice (Figure 3). Lung tissue stained with van Gieson elastic stain revealed a reduction in alveolar wall elastic fibers in RAR
/
,RXR
+/
mice
when compared with control mice (Figure 4). In contrast,
the elastic fiber density in airway and vascular walls was
not altered in the RAR
/
,RXR
+/
mice.
|
|
Alveolar Number Is Reduced in Mice Bearing the
RAR
/
Gene Deletion
A morphometric analysis was performed to compare parenchymal lung tissues from control mice and mice bearing the RAR
and RXR
gene deletions. At Postnatal
Day 28, wild-type mice had a mean body weight of 15.65 ± 0.75 g (mean ± SEM, n = 8), whereas mice bearing the
RAR
deletion alone had a mean weight of 11.29 ± 1.26 g
(mean ± SEM, n = 5, P < 0.02, Student's t test for unpaired variables). The weight of RAR
/
,RXR
+/
mice did not differ from that of RAR
/
,RXR
+/+
mice. Representative photographs in Figure 5 show that
the alveolar spaces were enlarged in both RAR
/
,
RXR
+/
(Figure 5B) and RAR
/
,RXR
+/
mice
(Figure 5C). This observation was confirmed by morphometric measurements (Table 1). The alveolar wall volume
density, Lm, alveolar surface area, and alveolar number
were significantly lower (P < 0.01) in the RAR
/
,
RXR
+/
group compared with the corresponding wild-type control group. RAR
/
,RXR
+/+ mice also had
fewer alveoli and a larger Lm than the corresponding control group, but the decreases were not as marked as in the
RAR
/
,RXR
+/
mice. Alveolar surface area was
not significantly lower in the RAR
/
,RXR
+/+ mice
when compared with the wild-type control group.
|
|
| |
Discussion |
|---|
|
|
|---|
Massaro and Massaro (24) have shown that tRA increases
alveolar number and the volume density of gas exchange
tissue in rats that received supplemental tRA during Postnatal Days 3 through 13. They also demonstrated that tRA
ameliorates the decreases in alveolar number and the volume density of gas exchange tissue that are induced by the
postnatal administration of dexamethasone (3, 24). Massaro and Massaro (29) had previously shown that postnatal
administration of dexamethasone is associated with thinning of the alveolar walls, which results from an attenuation of the normal developmental increase in the absolute
volume of interstitial cells that occurs between Postnatal
Days 6 and 14. The decrease in the volume of interstitial
cells was accompanied by a decrease in the volume of
lipid-laden fibroblasts and a decrease in the volume density of their lipid droplets. More recent studies by the same
investigators indicate that tRA increases alveolar number
and surface area in adult rats that developed pulmonary emphysema after receiving a single intratracheal administration of elastase (4). These important studies indicated
for the first time that alveolar septal formation could be
increased by a pharmacologic maneuver, but they did not
identify which RARs and which types of cells are involved.
Our previous findings indicate that the lipid-laden interstitial cell is centrally involved in the tRA-mediated effects
on elastin gene expression (12, 25). The present study
shows that elastin gene expression in neonatal LIF is increased by exogenous tRA and is influenced by RAR
-mediated signaling during alveolar formation in vivo but is
only one component of retinoic acid-mediated signaling
during alveolar formation.
We also desired to minimize the likelihood that the observed pulmonary abnormalities were secondary to defects that occurred outside the lung. RAR
is primarily expressed in skin and lung in adult mice, and the level of
RAR
expression is highest in lung fibroblasts immediately after birth and before the time when elastin gene expression reaches its maximum (25, 30). By studying mice
with a RAR
gene deletion, we focused on a nuclear retinoid receptor that predominates in pulmonary mesenchymal cells under the influence of endogenous ligands (16).
Previous studies using mice with RAR
1/RAR
or RXR
/
RAR
compound gene deletions demonstrated that RARs
were critically involved in embryonic lung development, as
the animals demonstrated lung hypoplasia or agenesis (18, 23). Because alveolar development occurs primarily postnatally in rodents, it was necessary to study a phenotype
that was not uniformly lethal during the fetal life or immediately postpartum.
The cooperative interactions between the deletion of
the RAR
gene and the RXR
gene that we observed in
alveolar formation have been shown to occur in other contexts (23). A detailed analysis of cardiac defects showed
that RAR
/
,RXR
+/
mice developed ventricular
thinning, whereas RAR
/
,RXR
+/+ mice did not
(23). Similarly, RAR
/
,RXR
+/
mice demonstrated a higher frequency of tracheal ring malformations
and ocular defects than did mice with either RXR
/
or RAR
/
deletions alone (23). It has been hypothesized that this phenomenon reflects the requirement that
the concentration of RXR
and RAR
both exceed critical thresholds to form RAR
/RXR
heterodimers (23).
The gradation of the effects that we observed in the severity of the elastin deficiency and alveolar enlargement progressing from RAR
/
to RAR
/
,RXR
+/
is
consistent with this hypothesis.
The early (by 4 wk) onset of alveolar air-space enlargement that we observed in RAR
/
mice is most consistent with a developmental defect in alveolar formation
rather than excessive elastic fiber destruction, which requires
longer to produce a morphometrically detectable defect.
This is illustrated in two genetic models of airspace enlargement in mice. Airspace enlargement that results from developmental abnormalities (either defects in the mottled locus
that reduce TE and lysyl oxidase, or a defective fibrillin-1 gene, which results in aberrant elastic fiber formation) is evident at 1 mo of age (31, 32). This contrasts with mice bearing a defect at the pallid locus in which airspace enlargement is thought to primarily represent the destruction of elastic fibers that is not evident until at least 8 mo of age (31, 33).
Alterations in TE mRNA associated with the RAR
/
genotype or retinoic acid administration were limited to LIF
and were not observed in whole lung tissue. One explanation for why LIFs may be unique in this regard follows from
our previous observations of RAR gene expression in isolated LIFs and whole lung tissue. Only LIFs demonstrated a
temporal correlation between the quantity of endogenous
retinoic acid and the level of RAR
mRNA (25). This indicates that RAR signaling in LIF may be more influenced by
endogenous retinoids than in other types of pulmonary cells. Alternatively, the regulation of elastin gene expression in
the LIF may be more dependent on both endogenous and
exogenous retinoids than is elastin gene expression in other
pulmonary mesenchymal cells where alternative regulatory
factors may dominate. Whatever explanation applies, one
can conclude that LIF are important contributors to alveolar
elastin synthesis because elastic fibers were reduced in
RAR
/
, RXR
+/
mice that had diminished TE
mRNA at Postnatal Day 12. Our studies do not exclude the
possibility that the role of the LIFs in the alveolar development of RAR
/
mice differs from their role in alveolar
development in wild-type mice.
Our observation that TE mRNA levels are similar in
whole lung tissue from control and RAR
/
mice at
Postnatal Day 12 is discrepant with our observation that
the content of elastin protein is less in RAR
/
mice at
Postnatal Day 28. Several factors may contribute to this
apparent disparity. First, a larger fraction of TE mRNA is
found in association with blood vessels at Postnatal Day 11 than at Postnatal Days 15 and 21 in the rat (34). Thus, the
level of TE mRNA in whole lung tissue is more heavily dependent on expression by blood vessels at Day 12 than at
older ages. Therefore, the level of TE mRNA whole lung
tissue at Day 12 is less representative of the expression in
alveolar wall fibroblasts than is the level of TE mRNA in
isolated LIFs. Because TE mRNA persists at higher levels
in the alveolar wall longer than in airways and vessels after
Postnatal Day 12, its translation would disproportionately contribute to the synthesis of elastin in the alveolar wall,
which is the most abundant location of elastin in the lung
at Day 28. Second, retinoid signaling may regulate other
processes involved in elastin synthesis and elastic fiber assembly that do not impact the steady-state levels of TE
mRNA, which only reflect pretranslational events. Elastic
fiber assembly is a complex process that is dependent on
an orderly progression of cellular growth, migration, differentiation, and the post-translational processing of proteins (8). Other proteins provide examples of how retinoids can alter one or more of these steps (35). Likewise,
retinoids have been shown to influence multiple cellular
functions that are involved in alveolar septal formation,
such as proliferation, migration, and terminal differentiation of cells (1). Further investigation will be required to
identify which cellular functions are involved in alveolar
septal formation and how retinoids influence them.
| |
Footnotes |
|---|
Abbreviations: complementary DNA, cDNA; lipid-laden interstitial fibroblast, LIF; mean cord length, Lm; messenger RNA, mRNA; polymerase chain reaction, PCR; retinoic acid receptor, RAR; retinoic acid-responsive element, RARE; ribosomal phosphoprotein P-0, RP-0; retinoid X receptor, RXR; standard error of the mean, SEM; tropoelastin, TE; all-trans retinoic acid, tRA.
(Received in original form August 18, 1999 and in revised form April 7, 2000).
Acknowledgments: These studies were supported by a grant from the Department of Veterans Affairs Research Service (S.E.M.), grant FY98-0836 from the March of Dimes Birth Defects Foundation (J.M.S.), and grants HL 53430 (S.E.M.) and HL 62861 (J.M.S. and S.E.M.) from the National Heart Lung and Blood Institute of the National Institutes of Health.
| |
References |
|---|
|
|
|---|
1. Chytil, F.. 1996. Retinoids in lung development. FASEB J. 10: 986-992 [Abstract].
2. Harrison, E. H.. 1993. Enzymes catalyzing the hydrolysis of retinyl esters. Biochim. Biophys. Acta 1170: 99-108 [Medline].
3.
Massaro, G., and
D. Massaro.
1996.
Postnatal treatment with retinoic acid
increases the number of alveoli in rats.
Am. J. Physiol. (Lung Cell. Mol. Physiol.)
270:
L305-L310
4. Massaro, G. D., and D. Massaro. 1997. Retinoic acid treatment abrogates elastase-induced pulmonary emphysema in rats. Nature Medicine 3: 675-677 [Medline].
5. Burri, P. H. 1985. Development and growth of the human lung. In Handbook of Physiology. A. P. Fishman, editor. Physiological Society, Bethesda, MD. 1-31.
6. Kida, K., and W. M. Thurlbeck. 1980. Lack of recovery of lung structure and function after the administration of beta-amino-proprionitrile in the postnatal period. Am. Rev. Respir. Dis. 122: 467-475 [Medline].
7. Boström, H., K. Willetts, M. Pekny, P. Leveen, P. Lindahl, H. Hedstrand, M. Pekna, M. Hellstrom, S. Gebre-Medin, M. Schalling, M. Nilsson, S. Kurland, J. Tornell, J. K. Heath, and C. Betsholtz. 1996. PGDF-A signaling is a critical event in lung alveolar myofibroblast development and alveogenesis. Cell 85: 863-873 [Medline].
8. Mariani, T. J., S. Sandefur, and R. A. Pierce. 1997. Elastin in lung development. Exp. Lung Res. 23: 131-145 [Medline].
9. Shenai, J. P., and F. Chytil. 1990. Vitamin A storage in lungs during perinatal development in the rat. Biol. Neonate 57: 126-132 [Medline].
10.
McGowan, S. E.,
M. M. Doro, and
S. K. Jackson.
1997.
Endogenous retinoids increase perinatal elastin gene expression in rat lung fibroblasts and
fetal explants.
Am. J. Physiol. (Lung Cell. Mol. Physiol.)
273:
L410-L416
11.
Wellik, D. M.,
D. H. Norback, and
H. F. DeLuca.
1997.
Retinol is specifically required during midgestation for neonatal survival.
Am. J. Physiol.
272:
E25-E29
12.
Liu, R.,
C. S. Harvey, and
S. E. McGowan.
1993.
Retinoic acid increases
elastin in neonatal rat lung fibroblast cultures.
Am. J. Physiol. (Lung Cell.
Mol. Physiol.)
265:
L430-L437
13.
Chen, H.,
S. Jackson,
M. Doro, and
S. McGowan.
1998.
Perinatal expression
of genes that may participate in lipid metabolism by lipid-laden lung fibroblasts.
J. Lipids Res.
39:
2483-2492
14. Kaplan, N. B., M. M. Grant, and J. S. Brody. 1985. The lipid interstitial cell of the pulmonary alveolus: age and species differences. Am. Rev. Respir. Dis. 132: 1307-1312 [Medline].
15.
Allenby, G.,
M. T. Bocquel,
M. Saunders, and
A. Levin.
1993.
Retinoic acid
receptors and retinoid X receptors: interactions with endogenous retinoic
acids.
Proc. Natl. Acad. Sci. USA
90:
30-34
16.
Dolle, P.,
E. Ruberte,
P. LeRoy,
G. Morriss-Kay, and
P. Chambon.
1990.
Retinoic acid receptors and cellular retinoid binding proteins: I. A systematic study of their differential pattern of transcription during mouse organogenesis.
Development
110:
1133-1151
17. Kastner, P., M. Mark, and P. Chambon. 1995. Nonsteroid nuclear receptors: what are genetic studies telling us about their role in real life? Cell 83: 859-869 [Medline].
18.
Luo, J.,
H. M. Sucov,
J. Bader,
R. M. Evans, and
V. Giguere.
1996.
Compound mutants for retinoic acid receptor (RAR)
and RAR
1 reveal developmental functions for multiple RAR-
isoforms.
Mech. Dev.
55:
33-44
[Medline].
19. Lohnes, D., P. Kastner, D. Andree, M. Mark, M. LeMuer, and P. Chambon. 1993. Function of retinoic acid receptor-gamma in the mouse. Cell 73: 643-658 [Medline].
20.
Kastner, P.,
J. M. Grondona,
M. Mark,
A. Gansmuller,
M. LeMuer,
D. Decimo,
J. L. Vonesch,
P. Dolle, and
P. Chambon.
1994.
Genetic analysis of
RXR-
development function: convergence of RXR and RAR signaling
pathways in heart and eye morphogenesis.
Cell
78:
987-1003
[Medline].
21.
Kastner, P.,
M. Mark,
M. Leid,
A. Gansmuller,
W. Chin,
J. M. Grondona,
D. Decimo,
W. Krezel,
A. Dierich, and
P. Chambon.
1996.
Abnormal spermatogenesis in RXR-
mutant mice.
Genes Dev.
10:
80-92
22. Dolle, P., V. Frqulob, P. Kastner, and P. Chambon. 1994. Developmental expression of murine retinoid X receptor (RXR) genes. Mech. Dev. 45: 91-104 [Medline].
23. Kastner, P., M. Mark, N. Ghyselinck, W. Krezel, V. Dupe, J. M. Grondona, and P. Chambon. 1997. Genetic evidence that the retinoid signal is transduced by heterodimeric RXR/RAR functional units during mouse development. Development 124: 313-326 [Abstract].
24. Massaro, G. D., and D. Massaro. 1996. Formation of pulmonary alveoli and gas-exchange surface area: quantitation and regulation. Annu. Rev. Physiol. 58: 73-92 [Medline].
25.
McGowan, S. E.,
C. S. Harvey, and
S. K. Jackson.
1995.
Retinoids, retinoic
acid receptors, and cytoplasmic retinoid binding proteins in perinatal rat
lung fibroblasts.
Am. J. Physiol. (Lung Cell. Mol. Physiol.)
269:
L463-L472
26. Prosser, I. W., K. R. Stenmark, S. Manish, E. C. Crouch, R. P. Mecham, and W. C. Parks. 1989. Regional heterogenity of elastin and collagen gene expression in intralobar arteries in response to hypoxic pulmonary hypertension as demonstrated by in situ hybridization. Am. J. Pathol. 135: 1073-1088 [Abstract].
27. Weibel, E. R. 1979. Stereological Methods. Academic, New York. 101-161.
28. Rosner, B. 1990. Fundamentals of Biostatistics. PWS-Kent Publishing Co., Boston. 246-473.
29. Massaro, D., and G. D. Massaro. 1986. Dexamethasone accelerates postnatal alveolar wall thinning and alters wall composition. Am. J. Physiol. 251: R218-R224 .
30.
Kastner, P.,
A. Krust,
C. Mendelsohn,
J. M. Garnier,
A. Zelent,
P. LeRoy,
A. Staub, and
P. Chambon.
1990.
Murine isoforms of retinoic acid receptor gamma with specific patterns of expression.
Proc. Natl. Acad. Sci. USA
87:
2700-2704
31. Keil, M., G. Lungarella, E. Cavarra, P. van Even, and P. A. Martorana. 1996. A scanning electron microscopic investigation of genetic emphysema in tight-skin, pallid, and beige mice, three different C57 bl/6J mutants. Lab. Invest. 74: 353-362 [Medline].
32. Gacheru, S., C. McGee, J. Y. Uriuhare, T. Kosonen, S. Packman, D. Tinker, S. A. Krawetz, K. Reiser, C. L. Keen, and R. B. Rucker. 1993. Expression and accumulation of lysyl oxidase, elastin, and type I procollagen in human Menkes and mottled mouse fibroblasts. Arch. Biochem. Biophys. 301: 325-329 [Medline].
33. Martorana, P. A., T. Brand, C. Gardi, P. van Even, M. M. de Santi, P. Calsoni, P. Marcolongo, and G. Lungarella. 1993. The pallid mouse: a model of genetic a1-antitrypsin deficiency. Lab. Invest. 68: 233-241 [Medline].
34. Noguchi, A., and H. Samaha. 1991. Developmental changes in tropoelastin gene expression in the rat lung studied by in situ hybridization. Am. J. Respir. Cell Mol. Biol. 5: 571-578 .
35. Means, A. L., and L. J. Gudas. 1995. The roles of retinoids in vertebrate development. Annu. Rev. Biochem. 64: 201-233 [Medline].
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Proc. Am. Thorac. Soc. | Am. J. Respir. Crit. Care Med. |